Biogelx
Newhouse
About Biogelx
Biogelx is a biomaterials company which designs and supplies peptide hydrogels for cell culture, precisely tuned to the requirements of the cell. These products have applications in fundamental cell research, toxicology/drug development and may ultimately be translated to cell therapy/regenerative medicine. The chemical and physical properties of the hydrogels match the characteristics experienced by cells within tissues, thus enabling the study and manipulation of cells in a realistic 3D environment which is simple, fully defined and tuneable. The Company's patented hydrogel products are currently selling in the US, Europe and Asia. The product's unique cell-matching capabilities clearly provide academic users, medical researchers and pharmaceutical companies with a serious alternative to competing 3D cell culture products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.3M
- Funding stage: Early Stage Venture
- Last round: Grant (May 2017)
- Website: biogelx.com
- Phone: +4401698534655
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biogelx-3252663 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.